Delivery Order SPE2DB24D1201-SPE2DB25FJDNP
Award Date 7/21/25
Potential Completion Date 8/11/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,851.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Esbriet (pirfenidone) 267 mg tablets in a quantity of 270 units. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 8, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,934.50 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Esbriet (pirfenidone) 801 mg. The award has an ultimate completion date of December 3, 2024 and was issued on November 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for 270 tablets of the drug Esbriet (pirfenidone) 267 mg. The contract has a completion date of June 27, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. The company also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,311.50 firm fixed-price delivery order is for the supply of 4,565,099 units of the prescription medication Esbriet (pirfenidone) 801 mg tablets. The contract has an ultimate completion date of July 30, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite...
- The Defense Logistics Agency awarded a $3,311.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562,186,779 Esbriet 267 mg tablets. As the prime contractor, Amerisourcebergen will deliver 270 tablets to a facility located in Conshohocken, Pennsylvania, under a schedule spanning from September 15, 2023 to October 6, 2023. The order was placed against an existing DLA contract vehicle to support the agency's medical supply needs. No set aside designation...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Esbriet 801 mg tablets, a medication used to treat pulmonary fibrosis. The contract has a firm fixed price of $3,425.95 and a period of performance through May 13, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price contract is for the delivery of Esbriet 267 mg capsules, a specialty medication. The contract has an ultimate completion date of December 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a ceiling value of $3,425.95 and a performance period through May 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 Firm Fixed Price delivery order is for the supply of Esbriet 267 mg tablets. This award is not designated as a set-aside contract. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of Esbriet 801 mg tablets, with a potential value of $3,311.50 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp is also the prime...